Recent Insider Transactions - Harrow (NASDAQ: HROW) - Life Science Report

Astria Therapeutics

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ HROW Harrow

BAUM MARK L / director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER

07/21/2025

Buy

$7.87

600,000

$4.722M

3.20M

NASDAQ HROW Harrow

BAUM MARK L / director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER

07/21/2025

Sell

$37.08

313,338

$11.619M

2.89M

Research Tools

News & Announcements

Popular Topics

Miscellaneous